Vitamin D3 shows promise for ulcerative colitis in new trial

This study tests whether taking vitamin D3 supplements can lower inflammation in people with moderate ulcerative colitis. Sixty adults aged 20-40 will either get standard care plus a placebo or standard care plus a high dose of vitamin D3 every two weeks for 12 weeks. Researchers will measure changes in blood and stool markers of inflammation and track disease activity and quality of life. The goal is to see if vitamin D3 can be a helpful add-on treatment for managing this chronic condition.